Neonatal Infection
47
9
13
22
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.1%
1 terminated out of 47 trials
95.7%
+9.1% vs benchmark
11%
5 trials in Phase 3/4
14%
3 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (47)
National Bacterial Meningitis Study in Children and Newborns
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Understanding COVID-19 Infection in Pregnant Women and Their Babies
Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19
Peripheral Fractional Tissue Oxygen Extraction and Infection in Term and Preterm Neonates
Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection
Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections
Exploring Vancomycin Disposition in Neonates
Prenatal Antibiotics and Breast Milk / Neonatal IgA
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection
COPE - COVID-19 in Pregnancy and Early Childhood
Effect of Chlorhexidine Versus Alcohol on Infections in Neonates
Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology.
Parental Participation on the Neonatal Ward - the neoPARTNER Study
Outcomes of Neonates Born to Mothers With SARS-CoV-2 Infection in Shanghai
The Investigation of the Neonates With or With Risk of COVID-19